REVLIMID identity
The active ingredient recorded for this profile is Lenalidomide. Confirm the prescribed brand or ingredient before comparing packages.
Specialty Care medication reference
REVLIMID price reference.
REVLIMID (Lenalidomide) has 15 European package references in this catalog. The listed range runs from 2.5 mg hard capsules · 7 capsules at €3,737.56 to 25 mg hard capsules · 21 capsules at €11,356.14. 6 package references also include recorded U.S. cash-price context ($18,295.20); compare only like-for-like strength, form and quantity. Figures are informational, not a quote or supply guarantee.
Estimated medicine cost range€3,737.56 – €11,356.14
Source-supported U.S. cash context$18,295.20
Estimated price differenceup to €6,582.11
Last recorded source review
Reference profile
Clear information.
Case-specific review.
The listed range runs from 2.5 mg hard capsules · 7 capsules at €3,737.56 to 25 mg hard capsules · 21 capsules at €11,356.14. These figures are catalog references, not an offer to sell or a guarantee of supply. The correct product, package, destination, licensed provider and importer must be reviewed for each request.
Package-level price scope
The listed range runs from 2.5 mg hard capsules · 7 capsules at €3,737.56 to 25 mg hard capsules · 21 capsules at €11,356.14. Strength, dosage form and quantity can materially change a like-for-like comparison.
Comparison evidence
6 package references also include recorded U.S. cash-price context ($18,295.20); compare only like-for-like strength, form and quantity.
Package references
REVLIMID listed formats
European figures are dated estimated medicine cost references. U.S. cash context appears only where the catalog retains source provenance; compare the exact strength, form and quantity.
15 of 15 package references shown
No package references match that search. Try a shorter strength, dosage form, supplier or PZN.
| Package reference | Estimated medicine cost reference | Comparable U.S. cash reference | Estimated difference | Source notes | Select |
|---|---|---|---|---|---|
| 2.5 mg hard capsules · 7 capsules Bristol-Myers Squibb GmbH & Co. KGaA · PZN 13743808 | €3,737.56 | Not listed | Case-specific comparison | Dated catalog record; current price and availability require review. Recorded review: | Request this package |
| 5 mg hard capsules · 7 capsules Bristol-Myers Squibb GmbH & Co. KGaA · PZN 13743814 | €3,837.45 | Not listed | Case-specific comparison | Dated catalog record; current price and availability require review. Recorded review: | Request this package |
| 7.5 mg hard capsules · 7 capsules Bristol-Myers Squibb GmbH & Co. KGaA · PZN 15253511 | €3,906.72 | Not listed | Case-specific comparison | Dated catalog record; current price and availability require review. Recorded review: | Request this package |
| 10 mg hard capsules · 7 capsules Bristol-Myers Squibb GmbH & Co. KGaA · PZN 13743820 | €3,975.96 | Not listed | Case-specific comparison | Dated catalog record; current price and availability require review. Recorded review: | Request this package |
| 15 mg hard capsules · 7 capsules Bristol-Myers Squibb GmbH & Co. KGaA · PZN 13743837 | €4,114.46 | Not listed | Case-specific comparison | Dated catalog record; current price and availability require review. Recorded review: | Request this package |
| 20 mg hard capsules · 7 capsules Bristol-Myers Squibb GmbH & Co. KGaA · PZN 15253497 | €4,248.01 | Not listed | Case-specific comparison | Dated catalog record; current price and availability require review. Recorded review: | Request this package |
| 25 mg hard capsules · 7 capsules Bristol-Myers Squibb GmbH & Co. KGaA · PZN 15253505 | €4,581.60 | Not listed | Case-specific comparison | Dated catalog record; current price and availability require review. Recorded review: | Request this package |
| 2.5 mg hard capsules · 21 capsules Bristol-Myers Squibb GmbH & Co. KGaA · PZN 10014405 | €9,424.09 | $18,295.20 | €6,582.11 | Drugs.com Revlimid cash reference normalized from 28 to 21 capsules Recorded review: | Request this package |
| 5 mg hard capsules · 21 capsules Bristol-Myers Squibb GmbH & Co. KGaA · PZN 01875255 | €9,723.71 | $18,295.20 | €6,282.49 | Drugs.com Revlimid cash reference normalized from 28 to 21 capsules Recorded review: | Request this package |
| 7.5 mg hard capsules · 21 capsules Bristol-Myers Squibb GmbH & Co. KGaA · PZN 11056179 | €9,931.48 | $18,295.20 | €6,074.72 | Drugs.com Revlimid cash reference normalized from 28 to 21 capsules; 7.5 mg uses the listed lower-strength brand unit reference because no exact U.S. 7.5 mg cash pack is listed Recorded review: | Request this package |
| 10 mg hard capsules · 21 capsules Bristol-Myers Squibb GmbH & Co. KGaA · PZN 01875261 | €10,139.25 | Not listed | Case-specific comparison | Dated catalog record; current price and availability require review. Recorded review: | Request this package |
| 10 mg hard capsules · 21 capsules Bristol-Myers Squibb GmbH & Co. KGaA | €10,139.26 | $18,295.20 | €5,866.94 | Drugs.com Revlimid cash reference normalized from 28 to 21 capsules | Request this package |
| 15 mg hard capsules · 21 capsules Bristol-Myers Squibb GmbH & Co. KGaA · PZN 01875278 | €10,554.78 | $18,295.20 | €5,451.42 | Drugs.com Revlimid 15 mg, 21-capsule cash reference Recorded review: | Request this package |
| 20 mg hard capsules · 21 capsules Bristol-Myers Squibb GmbH & Co. KGaA · PZN 11056162 | €10,955.46 | $18,295.20 | €5,050.74 | Drugs.com Revlimid 20 mg, 21-capsule cash reference Recorded review: | Request this package |
| 25 mg hard capsules · 21 capsules Bristol-Myers Squibb GmbH & Co. KGaA · PZN 01875284 | €11,356.14 | Not listed | Case-specific comparison | Dated catalog record; current price and availability require review. Recorded review: | Request this package |
Data scopeReference information, not a quote
Displayed amounts are dated catalog references and may not include every tax, dispensing, shipping or route-specific cost. Exact identity, availability, prescription, destination and import route require separate review. U.S. amounts are shown only for records with retained comparison provenance. US Med Access does not dispense or sell medicines and provides no medical advice. Review the pricing and data methodology before comparing packages.
How the references are preparedSources and editorial responsibility
Where this REVLIMID reference comes from
US Med Access publishes this page as an independent reference-information provider. Package records are retained with their available source notes and review dates; missing provenance is stated rather than inferred.
- Publisher and author
- US Med Access editorial team
- Recorded source review
- Reference scope
- 15 active European package records with supported U.S. cash-price context where listed
01
FDA Drugs@FDA record — RevlimidOfficial U.S. medicine record · accessdata.fda.gov
↗
02
FDA prescribing information — RevlimidOfficial U.S. medicine record · accessdata.fda.gov
↗
03
EMA medicine overview — RevlimidOfficial EU medicine record · ema.europa.eu
↗
04
Drugs.com medicine price guideU.S. cash-price context · drugs.com
↗
05
US Med Access pricing and data methodologyMethodology · usmedaccess.com
↗
Frequently asked questions
REVLIMID price and package questions
Direct answers based on the package records shown on this page. They do not replace medical, regulatory or dispensing advice.
01What is the listed REVLIMID price in Europe?
The 15 listed European package references range from €3,737.56 – €11,356.14. The exact amount depends on strength, dosage form and pack quantity, so compare the specific package row rather than the range alone.
02How does the REVLIMID European reference compare with U.S. cash prices?
Recorded U.S. cash-price context is $18,295.20 across 6 supported package references. A comparison is meaningful only where strength, form and quantity are equivalent; source notes identify normalization or limitations.
03Are the listed REVLIMID amounts a quote or sale offer?
No. They are informational catalog references. US Med Access is an independent sourcing consultant and does not sell or dispense medicines. Current availability, route, prescription and total cost require separate review.
04How do I request the correct REVLIMID package?
Select the row that matches the prescribed strength, dosage form and quantity, then include the destination and request details. A package-level review is required before any next step.
Availability and logistics
Need a package-level review?
Start with the medication, package and destination. The sourcing team will assess the specific request without promising a supply, import or delivery outcome.